Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥941.00 JPY
Change Today -3.00 / -0.32%
Volume 43.9K
3151 On Other Exchanges
Symbol
Exchange
Tokyo
As of 1:00 AM 03/6/15 All times are local (Market data is delayed by at least 15 minutes).

vital ksk holdings inc (3151) Snapshot

Open
¥944.00
Previous Close
¥944.00
Day High
¥964.00
Day Low
¥940.00
52 Week High
09/26/14 - ¥999.00
52 Week Low
03/17/14 - ¥656.00
Market Cap
57.6B
Average Volume 10 Days
35.3K
EPS TTM
¥84.90
Shares Outstanding
61.2M
EX-Date
03/27/15
P/E TM
11.1x
Dividend
¥18.00
Dividend Yield
1.70%
Current Stock Chart for VITAL KSK HOLDINGS INC (3151)

Related News

No related news articles were found.

vital ksk holdings inc (3151) Related Businessweek News

No Related Businessweek News Found

vital ksk holdings inc (3151) Details

Vital Ksk Holdings, Inc. is engaged in the wholesale and retail of pharmaceutical products in Japan. It is involved in the wholesale of veterinary drugs. The company is also engaged in the wholesale of agricultural chemicals and materials; dispensing pharmacy activities; and transportation, nursing care, parking, mail order of health related products, and real estate management businesses. In addition, it provides medical management consulting services; and operates as an insurance agent and OTC drug manufacturer. Vital Ksk Holdings, Inc. is headquartered in Tokyo, Japan.

3,413 Employees
Last Reported Date: 06/30/14

vital ksk holdings inc (3151) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

vital ksk holdings inc (3151) Key Developments

Vital KSK Holdings Inc. Reports Consolidated Earnings Results for the Third Quarter Ended December 31, 2014; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2015; Provides Dividend Guidance for the Year End of Fiscal 2015

VITAL KSK HOLDINGS, INC. reported consolidated earnings results for the third quarter ended December 31, 2014. For the period, the company has posted net sales of ¥415,531 million against ¥428,221 million a year ago. Operating income was ¥1,796 million against ¥2,644 million a year ago. Ordinary income was ¥5,410 million against ¥5,357 million a year ago. Net income was ¥4,067 million or ¥71.00 per share against ¥3,431 million or ¥58.08 per share a year ago. Income before income taxes and minority interests was ¥5,811 million against ¥5,499 million a year ago. The company provided earnings guidance for the fiscal year ending March 31, 2015. For the fiscal year, the company expects net sales of ¥551,600 million, operating income of ¥1,800 million, ordinary income of ¥6,000 million and net income of ¥4,300 million or ¥75.51 per share. The company also provided cash dividend guidance for the year end of fiscal 2015. For the year end, the company expects to pay a cash dividend of ¥10.00 per share compared to ¥8.00 per share paid a year ago.

Vital KSK Holdings Inc. to Report Q3, 2015 Results on Feb 05, 2015

Vital KSK Holdings Inc. announced that they will report Q3, 2015 results at 2:00 PM, Tokyo Standard Time on Feb 05, 2015

Vital Ksk Holdings, Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2014; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2015; Announces Dividend for the Second Quarter of Year Ending March 31, 2015, Payable on December 1, 2014; Provides Dividend Guidance for the Year Ending March 31, 2015

VITAL KSK HOLDINGS, INC. reported consolidated earnings results for the six months ended September 30, 2014. For the period, the company has posted net sales of ¥265,486 million against ¥276,227 million a year ago. Operating income was ¥724 million against ¥1,193 million a year ago. Ordinary income was ¥3,233 million against ¥2,905 million a year ago. Net income was ¥2,536 million or ¥43.61 diluted per share against ¥1,945 million or ¥32.82 per share a year ago. Income before income taxes and minority interests was ¥3,520 million against ¥3,044 million a year ago. Net cash provided by operating activities was ¥735 million against net cash used in operating activities of ¥18,110 million a year ago. Purchase of property, plant and equipment was ¥2,841 million against ¥2,297 million a year ago. Purchase of intangible assets was ¥446 million against ¥304 million a year ago. Purchase of investment securities was ¥21 million against ¥271 million a year ago. For the fiscal year ending March 31, 2015, the company expects net sales of ¥551,600 million, operating income of ¥1,800 million, ordinary income of ¥6,000 million and net income of ¥4,300 million or ¥75.51 per share. The company announced dividend of ¥8.00 per share for the second quarter of year ending March 31, 2015. Scheduled date of commencing dividend payments is December 1, 2014 The company also provided dividend guidance for the year ending March 31, 2015. The company expects to pay a dividend of ¥10.00 per share compared to ¥8.00 per share paid a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3151:JP ¥941.00 JPY -3.00

3151 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 3151.
View Industry Companies
 

Industry Analysis

3151

Industry Average

Valuation 3151 Industry Range
Price/Earnings 11.5x
Price/Sales 0.1x
Price/Book 0.8x
Price/Cash Flow 11.8x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITAL KSK HOLDINGS INC, please visit www.vitalksk.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.